Pheochromocytoma in von Hippel-Lindau disease: Clinical presentation and mutation analysis in a large, multigenerational kindred

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 1, 1998, Pages 117-120

  Atuk, Nuzhet O ^a   Stolle, Catherine ^b   Owen Jr , John A ^b   Carpenter, Johnson T ^b   Vance, Mary Lee ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIGREE ANALYSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCHOOL CHILD; VON HIPPEL LINDAU DISEASE;

ADENOMA; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGE OF ONSET; AGED; CARCINOMA, RENAL CELL; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HIPPEL-LINDAU DISEASE; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PEDIGREE; PHENOTYPE; PHEOCHROMOCYTOMA; POINT MUTATION; RETINAL NEOPLASMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0031792734     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.1.117     Document Type: Article

References (15)

1. Melmon KL, Rosen SW. 1964 Lindau's Disease, review of the literature, and study of a large kindred. Am J Mod. 36:595-617.
2. Maher ER, Yates JRW, Harries R, et al. 1990 Clinical features and natural history of von Hippel-Lindau Disease. Q J Med. 77:1151-1163.
3. Hosoe S, Braicch H, Latif F, et al. 1990 Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics. 8:634-640.
4. Latif F, Tory K, Gnarra J, et al. 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1317-1320.
5. Crossey PA, Eng C, Foster K, et al. 1994 Identification of intragenic mutations in von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet. 3:1303-1308.
6. Chen F, Kishida T, Masahiro Y, et al. 1995 Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat. 5:66-75.
7. Mulholland SG, Atuk NO, Walzak MP. 1969 Familial pheochromocytoma, associated with cerebellar hemangioblastoma. JAMA. 207:1709-1711.
8. Atuk NO, McDonald T, Wood T, et al. 1979 Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease: a ten year study of a large family. Medicine. 58:209-218.
9. Atuk NO, Hanks JB, Weltman J, Bogdonoff DL, Boyd DG, Vance ML. 1994 Circulating dihydroxyphenlglycol and norepinephrine concertrations during sympathetic nervous system activation in patients with pheochromocytoma. J. Clin Endocrinol Metab. 79:1609-1614.
10. Atuk NO, Bailey CI, Turner, SM, Peach MJU, Westervelt FB. 1976 Red blood cell catechol-O-methyl transferase, plasma catecholamines and renin in renal failure. Trans Am Soc Artificial Organ. XXII:195-200.
11. Green JS, Bowmer MI, Johnson GJ. 1986 von Hippel-Lindau disease in a New Foundland kindred. Can Med Assoc J. 134:133-146.
12. Whaley JM, Naglich JGL, Hsia YE, et al. 1944 Germ-line mutations in the von Hippel Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet. 55:1092-102.
13. Breakefield OX, Giller EL, Nurnberger Ji, Castiglione CM, Buchsbaum MS, Gershorn ES. 1980 Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness. Psych Res. 2:307-314.
14. Duan DR, Pause A, Burgess WH, et al. 1995 Inhibition of transcription elongation by the VHI, tumor suppressor protein. Science. 269:1402-1406.
15. Kibel A, Iliopoulos O, DeCaprio A, Kaelin Jr WG. 1995 Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science. 269:1444-1446.